Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FE0M2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,889
Award facts
- Contract value 100% obligated
- $51,888.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51,888.85 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on August 13, 2025. The contract employs firm fixed price terms with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was awarded through open competition. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for federal military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its extensive capability in supplying specialty pharmaceuticals across multiple therapeutic domains. Dupixent, an immunosuppressant medication used in the treatment of conditions such as atopic dermatitis, eczema, and asthma, represents one of the specialized pharmaceutical products the company routinely delivers to support Defense Health Agency operations and other federal healthcare customers through its DLA prime vendor agreements.
Quick answers
Who was awarded contract SPE2DB25FE0M2?
SPE2DB25FE0M2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FE0M2 worth?
The government has obligated $51,889 on SPE2DB25FE0M2.
Is contract SPE2DB25FE0M2 an order under another contract?
Yes. SPE2DB25FE0M2 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE0M2 competed?
The extent of competition for SPE2DB25FE0M2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award